Literature DB >> 8609520

Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment.

G Piccolo, D Franciotta, M Versino, E Alfonsi, M Lombardi, G Poma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609520      PMCID: PMC1073866          DOI: 10.1136/jnnp.60.3.348

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness.

Authors:  A Gaur; G Ruberti; R Haspel; J P Mayer; C G Fathman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

2.  IFN-alpha treatment suppresses the development of experimental autoimmune myasthenia gravis.

Authors:  M Shenoy; S Baron; B Wu; E Goluszko; P Christadoss
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

3.  Ocular pseudo-myasthenic reaction induced by interferon in an AIDS patient.

Authors:  R R Riedel; A Schmitt; A Hartmann
Journal:  Klin Wochenschr       Date:  1991-12-11

4.  Myasthenia gravis during interferon alfa therapy.

Authors:  A P Batocchi; A Evoli; S Servidei; M T Palmisani; F Apollo; P Tonali
Journal:  Neurology       Date:  1995-02       Impact factor: 9.910

5.  Soluble CD8 and soluble CD4 antigens in viral hepatitis and alcoholic cirrhosis.

Authors:  F Pfeffel; J Pidlich; D Petermann; C Müller
Journal:  J Hepatol       Date:  1994-02       Impact factor: 25.083

  5 in total
  5 in total

Review 1.  Current and future therapies for myasthenia gravis.

Authors:  Q Yi; A K Lefvert
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

2.  Low dose interferon-alpha is safe in patients with myasthenia gravis.

Authors:  H Bolay; R Karabudak; K Varli; O Saribas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

Review 3.  Cytokine-induced autoimmune disorders.

Authors:  P Miossec
Journal:  Drug Saf       Date:  1997-08       Impact factor: 5.606

4.  Myasthenia gravis: another autoimmune disease associated with hepatitis C virus infection.

Authors:  S Eddy; R Wim; V E Peter; R Tanja; T Jan; V S Werner
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

5.  Myasthenia Crisis Induced by Pegylated-Interferon in Patient With Chronic Hepatitis C: A Case Report.

Authors:  Su Jung Baik; Tae Hun Kim; Hye In Kim; Jeong Yeon Rhie
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.